Celsion Corporation is a fully integrated oncology company with a high-potential portfolio of innovative cancer treatments. With platform technologies in chemotherapy and gene-mediated immunotherapy, and RNAi engineered to enhance the clinical benefits of proven agents, Celsion’s mission is transformational. We seek to combine product technologies with novel targeting strategies to support our ultimate goal of improving survival and providing cures for challenging cancers. ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, is our lead product candidate. ThermoDox is currently being evaluated in the OPTIMA Study, a global phase 3 clinical trial for the treatment of primary liver cancer. Next in our pipeline is GEN-1, a highly promising treatment that incorporates a DNA plasmid encoding IL-12 into a unique nanoparticle delivery system. GEN-1 immunotherapy is currently being evaluated in the phase I/II OVATION 2 Study, in combination with chemotherapy, for newly diagnosed ovarian cancer patients.
Looking for a particular Celsion Corporation employee's phone or email?
Celsion Corporation Questions
The Celsion Corporation annual revenue was $500000 in 2026.
Khursheed Anwer is the Executive Vice President and Chief Science Officer of Celsion Corporation.
18 people are employed at Celsion Corporation.
Celsion Corporation is based in Lawrenceville, New Jersey.
The NAICS codes for Celsion Corporation are [541, 32541, 54, 32, 3254, 325].
The SIC codes for Celsion Corporation are [87, 873, 8733, 8731].
Top Celsion Corporation Employees
-
35 -
Tony Deasey
EVP and CFO at Celsion Corporation
Severna Park, MD, US11 -
25
-
14
-
13
-
15+
-
13
Related Companies
